BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 14625208)

  • 1. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
    Lupi R; Del Guerra S; Marselli L; Bugliani M; Boggi U; Mosca F; Marchetti P; Del Prato S
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E560-7. PubMed ID: 14625208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and mechanism of rosiglitazone on the impairment of insulin secretion induced by free fatty acids on isolated rat islets.
    Tian JY; Li G; Gu YY; Zhang HL; Zhou WZ; Wang X; Zhu HD; Luo TH; Luo M
    Chin Med J (Engl); 2006 Apr; 119(7):574-80. PubMed ID: 16620699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.
    Sugden MC; Bulmer K; Augustine D; Holness MJ
    Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition.
    Patanè G; Anello M; Piro S; Vigneri R; Purrello F; Rabuazzo AM
    Diabetes; 2002 Sep; 51(9):2749-56. PubMed ID: 12196468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of free fatty acids on beta-cell functions: a possible involvement of peroxisome proliferator-activated receptors alpha or pancreatic/duodenal homeobox.
    Yoshikawa H; Tajiri Y; Sako Y; Hashimoto T; Umeda F; Nawata H
    Metabolism; 2001 May; 50(5):613-8. PubMed ID: 11319727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.
    Patanè G; Piro S; Rabuazzo AM; Anello M; Vigneri R; Purrello F
    Diabetes; 2000 May; 49(5):735-40. PubMed ID: 10905481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipotoxicity in human pancreatic islets and the protective effect of metformin.
    Lupi R; Del Guerra S; Fierabracci V; Marselli L; Novelli M; Patanè G; Boggi U; Mosca F; Piro S; Del Prato S; Marchetti P
    Diabetes; 2002 Feb; 51 Suppl 1():S134-7. PubMed ID: 11815472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells.
    Dubois M; Pattou F; Kerr-Conte J; Gmyr V; Vandewalle B; Desreumaux P; Auwerx J; Schoonjans K; Lefebvre J
    Diabetologia; 2000 Sep; 43(9):1165-9. PubMed ID: 11043863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
    Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells.
    Blumentrath J; Neye H; Verspohl EJ
    Cell Biochem Funct; 2001 Sep; 19(3):159-69. PubMed ID: 11494305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.
    Zhou YP; Grill V
    J Clin Endocrinol Metab; 1995 May; 80(5):1584-90. PubMed ID: 7745004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)].
    Dubois M; Vantyghem MC; Schoonjans K; Pattou F
    Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):511-23. PubMed ID: 12527853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-peptidyl low molecular weight radical scavenger IAC protects human pancreatic islets from lipotoxicity.
    D'Aleo V; Del Guerra S; Martano M; Bonamassa B; Canistro D; Soleti A; Valgimigli L; Paolini M; Filipponi F; Boggi U; Del Prato S; Lupi R
    Mol Cell Endocrinol; 2009 Oct; 309(1-2):63-6. PubMed ID: 19481137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
    Matsui J; Terauchi Y; Kubota N; Takamoto I; Eto K; Yamashita T; Komeda K; Yamauchi T; Kamon J; Kita S; Noda M; Kadowaki T
    Diabetes; 2004 Nov; 53(11):2844-54. PubMed ID: 15504964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between adipose phosphoenolpyruvate carboxykinase and occurrence and reversion of insulin resistance].
    Zhao WH; Xiao JZ; Yang WY; Wang N; Wang X; Chen XP; Bu S
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3074-8. PubMed ID: 16324411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
    Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS
    Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone reverses insulin secretion altered by chronic exposure to free fatty acid via IRS-2-associated phosphatidylinositol 3-kinase pathway.
    Yang L; An HX; Deng XL; Chen LL; Li ZY
    Acta Pharmacol Sin; 2003 May; 24(5):429-34. PubMed ID: 12740178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
    Yajima K; Hirose H; Fujita H; Seto Y; Fujita H; Ukeda K; Miyashita K; Kawai T; Yamamoto Y; Ogawa T; Yamada T; Saruta T
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E966-71. PubMed ID: 12676649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids.
    Del Guerra S; Bugliani M; D'Aleo V; Del Prato S; Boggi U; Mosca F; Filipponi F; Lupi R
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):22-5. PubMed ID: 19758793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.